{"schema_version":"secwatch.filing_event.v1","accession":"0001023459-24-000105","form_type":"8-K","ticker":"SLP","cik":"0001023459","company_name":"Simulations Plus, Inc.","filed_at":"2024-08-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.922504+00:00","generated_at":"2026-05-31T07:47:04.285060+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Simulations Plus Announces Leadership Changes and Business Unit Restructuring","bullets":["Steven Chang promoted to President, Quantitative Systems Pharmacology, effective August 30, 2024.","Jenna Rouse named President of newly formed Adaptive Learning & Insights business unit.","Murry Alper named President of newly formed Medical Communications business unit.","Sandra Suarez-Sharp transitions to President, Regulatory Strategies Center of Excellence.","Brett Howell (former President, QSP) and Michael Raymer depart after assisting transition."],"urls":{"canonical":"https://secwatch.observer/filing/0001023459-24-000105","json":"https://secwatch.observer/filing/0001023459-24-000105.json","markdown":"https://secwatch.observer/filing/0001023459-24-000105.md","text":"https://secwatch.observer/filing/0001023459-24-000105.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023459/000102345924000105/0001023459-24-000105-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023459/000102345924000105/slp-20240823.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:47:04.285060+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"84a26ea43e","claim":"Brett Howell departed as President, Quantitative Systems Pharmacology at Simulations Plus, Inc..","evidence_excerpt":"Effective August 30, 2024, Dr. Brett Howell, Ph.D., has departed the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1023459/000102345924000105/0001023459-24-000105-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"President, Quantitative Systems Pharmacology"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}